Sectors
RGEN
Repligen Corporation
175.42
2 x 160.34
2 x 190.28
bid
ask
-
8.75
4.75%
2 @ 04:00 PM
175.42 +0.00 (0.00%)
| Ytd | 7.05% | |
| 1y | 13.50% |
172.39
day range
185.98
102.87
52 week range
194.57
| Open | 183.81 | Prev Close | 184.17 | Low | 172.39 | High | 185.98 | Mkt Cap | 11.14B |
| Vol | 1.21M | Avg Vol | 1.21M | EPS | 0.73 | P/E | 240.30 | Forward P/E | 65.71 |
| Beta | 1.08 | Short Ratio | 7.18 | Inst. Own | 105.51% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-27 | 50-d Avg | 175.47 | 200-d Avg | 144.08 | 1yr Est | 197.95 |
RGEN News
defenseworld.net
Repligen Corporation $RGEN Stock Sold by Krilogy Financial LLC
Krilogy Financial LLC lowered its position in shares of Repligen Corporation (NASDAQ: RGEN) by 31.8%
seekingalpha.com
Repligen: A Buy As Its Growth Engine Gears Up
Repligen demonstrates 13% organic growth despite Filtration headwinds, with strong momentum in the P
globenewswire.com
Repligen to Report Third Quarter 2026 Financial Results
WALTHAM, Mass., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), today announce
benzinga.com
Barclays Maintains Overweight on Repligen, Raises Price Target to $225
Barclays analyst Luke Sergott maintains Repligen (NASDAQ:RGEN) with a Overweight and raises the p
benzinga.com
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities w